Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
marked decrease » marked increase (Expand Search)
work increase » work increases (Expand Search), woman increase (Expand Search), fold increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
marked decrease » marked increase (Expand Search)
work increase » work increases (Expand Search), woman increase (Expand Search), fold increase (Expand Search)
-
1
Basic characteristics of the afforested land.
Published 2025“…Although afforestation increased POC contents in both soil layers (9.70 and 7.82 g·kg ⁻ ¹, respectively), it markedly reduced the more stable MAOC contents (from 9.53 and 9.62 g·kg ⁻ ¹ to 7.53 and 6.08 g·kg ⁻ ¹ in the 0–0.15 m and 0.15–0.30 m layers, respectively) and MAOM mass fractions (from 77.46% to 68.16% and from 78.69% to 71.61%). …”
-
2
-
3
Table 1_The impact of diagnosis-related group-based medical insurance payment model on the prognosis and nursing care of patients undergoing composite trabeculectomy: a retrospecti...
Published 2025“…Furthermore, the reform was associated with a marked decrease in hospitalization expenses and nursing costs. …”
-
4
DataSheet1_RETRACTED: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.DOCX
Published 2025“…Treatments with TSA and SurR9-C84A for 40 min led to improvement in the conjunctival and corneal tissue integrity, marked by an increase in clathrin, and claudin expressions. …”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
<i>mig-21</i> sensitizes adult DTCs to polarizing signals.
Published 2025“…However, migration cessation is not rescued; a significant increase in “overmigration” defects is observed between marked control (n=4/57) and <i>mig-21(u787)</i> on <i>vab-3</i> RNAi (n=17/65), p < 0.05. …”
-
15
-
16
Image 4_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff
Published 2025“…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
-
17
Data Sheet 2_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.pdf
Published 2025“…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
-
18
Data Sheet 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.pdf
Published 2025“…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
-
19
Image 2_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff
Published 2025“…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
-
20
Image 3_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff
Published 2025“…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”